Prevalencia de la neoplasia intraepitelial cervical y factores asociados en mujer de 25 a 35 años en el Hospital IESS Ceibos durante el año 2018 – 2020.

Abstract

Objective: to estimate the prevalence of cervical intraepithelial neoplasia 1, 2 and 3 and its associated factors in female patients of reproductive age at IESS Ceibos Hospital during the period from 2018 to 2020. Methodology: observational - analytical cross-sectional study. Summary measures, both of dispersion and position, will be performed for quantitative type variables, such as mean, median and mode, as well as variance and standard deviation. In the case of qualitative variables, a frequency analysis will be performed, where, in the case of determining the association of variables, the Chi-square test and Pearson's correlation will be performed. The total sample was 157 women aged 25 to 35 years. The patients were selected by stratified probability sampling. Result: The overall prevalence of CIN was calculated and found to be 52%, a little more than half of the women attended. It was found that the average age of the women attended of reproductive age with CIN was 30.41 years, the most frequent age being 33 years, as well as a minimum age of 25 years, a maximum of 35 years and a standard deviation of 2.97 years (Table 1 and Graph 1). Similarly, it could be observed that in 2019a greater number of patients were attended, representing 38.5% of the total (Table 2). Regarding the place of origin of the patients with CIN, 83.33% of them came from the province of Guayas, followed by the province of Manabí with 7.05%. Conclusion: We conclude that the prevalence of cervical intraepithelial neoplasia in women of fertile age in three years of study was 5.2%. Among the associated factors present in the women we found that 95% had more than 3 sexual partners during their lifetime, 53.8% of women used condoms consistently and 82.7% had had more than 2 Pap smears during their lifetime. As for sexually transmitted infections, the most prevalent was HPV infection, present in 48.7% of the women.